Tumor growth was modestly, although non-significantly, suppressed in cells stably expressing FLCNF118D/ FNIP2 consistent with the more attenuated rescue of TFEB phosphorylation in vivo (Fig. S9e, f) compared to what was observed in vitro, potentially due to issues with long-term expression of these constructs. The gene discussed is TFEB; the disease is neoplasm.